Outcomes of Acute Myocardial Infarction in Patients with Influenza and Other Viral Respiratory Infections

American Journal of Medicine

Volumn 132, Issue 10, 2019, Pages 1173-1181

  Vejpongsa, Pimprapa ^a,b   Kitkungvan, Danai ^a,b   Madjid, Mohammad ^a,b   Charitakis, Konstantinos ^a,b   Anderson, H Vernon ^a,b   Arain, Salman ^a,b   Balan, Prakash ^a,b   Smalling, Richard W ^a,b   Dhoble, Abhijeet ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b EAST TEXAS MEDICAL CENTER   (United States)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Cardiac catheterization; Coronary angiography; Influenza; Viral respiratory infections

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; AGED; ARTICLE; BLOOD TRANSFUSION; CASE FATALITY RATE; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY RECANALIZATION; FEMALE; HUMAN; INFLUENZA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VIRAL RESPIRATORY TRACT INFECTION; COMPLICATION; HEART INFARCTION; MIDDLE AGED; MORTALITY; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85068906072     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2019.05.002     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention (CDC). Weekly U.S. Influenza Surveillance Report. 2017-2018 Influenza season week 4 ending January 27, 2018. Available at: https://www.cdc.gov/flu/weekly/index.htm#S6. Accessed 02/2019.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
4. Ludwig A, Lucero-Obusan C, Schirmer P, Winston C, Holodniy M. Acute cardiac injury events ≤ 30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012. BMC Cardiovasc Disord. 2015;15:109.
5. Barnes M, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015;101:1738-1747.
6. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378:345-353.
7. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-2618.
8. Madjid M, Vela D, Khalili-Tabrizi H, Casscells SW, Litovsky S. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J. 2007;34:11-18.
9. Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003;107:762-768.
10. Haidari M, Wyde PR, Litovsky S, et al. Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis. 2010;208:90-96.
11. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
12. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004;35:1941-1945.
13. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Statistical Software Components 2015. Available to: https://ideas.repec.org/c/boc/bocode/s432001.html. Accessed 06/2019.
14. Public Health Weekly Reports for November 11, 1932. Public Health Rep 1932;47:2159-2189.
15. Falsey AR, Walsh EE, Francis CW, et al. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J Infect Dis. 2001;183:995-999.
16. Lagrand Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96-102.
17. Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:726-732.
18. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 1995;25(suppl 2):S9-S12.
19. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718-1720.
20. Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation. 2013;128:1910-1923.
21. Warren-Gash C, Hayward AC, Hemingway H, et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis. 2012;206:1652-1659.
22. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J. 2007;28:1205-1210.
23. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102:3039-3045.
24. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation. 2003;108:2730-2736.
25. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-1332.
26. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 2000;152:674-677.
27. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310:1711-1720.
28. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J. 2004;25:25-31.
29. MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102:1953-1956.
30. Madjid M, Curkendall S, Blumentals WA. The influence of oseltamivir treatment on the risk of stroke after influenza infection. Cardiology. 2009;113:98-107.
31. Casscells Casscells SW, Granger E, Kress AM, et al. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes. 2009;2:108-115.
32. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;58:2432-2446.
33. Madjid M, Alfred A, Sahai A, Conyers JL, Casscells SW. Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease. Tex Heart Inst J. 2009;36:546-552.
34. Matias G, Taylor R, Haguinet F, Schuck-Paim C, Lustig R, Shinde V. Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status. BMC Public Health. 2017;17(1):271.
35. Iqbal S, Li R, Gargiullo P, Vellozzi C. Relationship between Guillain-Barre syndrome, influenza-related hospitalizations, and influenza vaccine coverage. Vaccine. 2015;33:2045-2049.